Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
Public ClinicalTrials.gov record NCT01602614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Pharmacokinetics and Pharmacodynamics of Ganciclovir in Premature Infants Receiving Treatment for Cytomegalovirus Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a clinical sampling study, and no study drugs will be administered under this protocol. Premature infants who receive intravenous ganciclovir as part of clinical care will be eligible for participation in this study. Intravenous ganciclovir will not be provided under this protocol.
Study identification
- NCT ID
- NCT01602614
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 18 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 1 Day to 180 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2013
- Primary completion
- Feb 28, 2019
- Completion
- Feb 28, 2019
- Last update posted
- Jun 1, 2020
2013 – 2019
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72202 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| University of South Florida School of Medicine | St. Petersburg | Florida | 33701 | — |
| Louisiana State University Health Science Center - Shreveport | Shreveport | Louisiana | 71103 | — |
| Johns Hopkins Medical Institutions | Baltimore | Maryland | 21287 | — |
| Washington University in St Louis School of Medicine | St Louis | Missouri | 63110 | — |
| Steven & Alexandra Cohen Children's Medical Center of New York (CCMC) | Manhasset | New York | 11030 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Carolinas Medical Center - Charlotte | Charlotte | North Carolina | 28203 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| Nationwide Childrens Hospital | Columbus | Ohio | 43205 | — |
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | 15224 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cytomegalovirus Infections trials
Other public records listing Cytomegalovirus Infections. Sorted by last update posted; newest first. Not a recommendation.
- NCT05234723: Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients Recruiting
- NCT06407232: Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients Recruiting
- NCT05183490: R-MVST Cells for Treatment of Viral Infections Recruiting
- NCT06066957: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients Recruiting
- NCT02982902: T Cell Therapy of Opportunistic Cytomegalovirus Infection Recruiting
- NCT06909110: Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01602614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2020 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01602614 live on ClinicalTrials.gov.